PCMag.com is a leading authority on technology, delivering lab-based, independent reviews of the latest products and services. Our expert industry analysis and practical solutions help you make better ...

On Friday, BridgeBio Pharma Inc (BBIO) stock saw a modest uptick, ending the day at $23.42 which represents a slight increase of $0.18 or 0.77% from the prior close of $23.24. The stock opened at $23.

As the rising star of cell therapy biotechs, Iovance Biotherapeutics ( IOVA 3.76%) is a hot stock that's capturing a lot of ...

BridgeBio Pharma (BBIO) wins FDA nod Attruby for rare heart disorder, ATTR-CM challenging Pfizer's (PFE) Vyndaqel. Read more ...

The U.S. Food and Drug Administration has approved BridgeBio's drug for a rare and deadly heart condition, the company said ...

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In this article, we are going to ...

Two kittens from River Cities Humane Society are looking for a foster home! If you want to become a pet foster parent call ...

President-elect Donald Trump announced on Nov. 21 that he had chosen Pam Bondi, a longtime supporter of his and Florida’s ...

Trump said in a statement on Nov. 22 that Dr. Nesheiwat has "an unwavering commitment to saving and treating thousands of ...

The Food and Drug Administration approved on Friday a new medicine from BridgeBio for patients with a progressive heart ...

The approval of Attruby for transthyretin amyloidosis with cardiomyopathy begins a battle for control of a lucrative market ...